Akrami Fariba, Shahandashti Elaheh Ferdosi, Yahyapour Yousef, Sadeghi Mohsen, Khafri Soraya, Pournajaf Abazar, Rajabnia Ramazan
Department of Microbiology, Faculty of Medicine, Babol University of Medical Sciences, Babol, Islamic Republic of Iran.
Infectious Diseases and Tropical Medicine Research Center, Babol University of Medical Sciences, Babol, Islamic Republic of Iran.
Microb Pathog. 2017 Aug;109:35-38. doi: 10.1016/j.micpath.2017.05.005. Epub 2017 May 4.
Multi-drug resistant isolates of Acinetobacter baumannii have created therapeutic problems worldwide. This current study was intended to determine the Integron types, gene cassettes and antimicrobial resistance profile of A. baumannii isolated from BAL samples in Babol, north of Iran. During a 15-month period, 35 A. baumannii isolates were studied. Different classes of antimicrobial agents were used to determine the resistance ratios. Multiplex-PCR was used to detect different types of integrons and associated gene cassettes. The resistance rates to GM, FEP, AK, TOB, CP, PIP, SAM, IPM, SXT, CTX, CAZ, CL, TIM, MEM, and TZP were 85.7%, 100%, 91.4%, 68.5%, 94.3%, 88.5%, 97.1%, 94.3%, 100%, 100%, 100%, 0.0%, 91.4%, 94.3% and 91.4%, respectively. The distribution analysis of int genes showed that 25.7%, 88.6% and 28.6% of isolates carried the intI, intII and intIII genes, respectively. The prevalence of aadB, dfrA1, bla-OXA and aadA1 genes were 94.3%, 77.1%, 40% and 5.7%, respectively. The current study showed that a high level of A. baumannii isolates harbor integrons in our therapeutic center, which may lead to distribution of multiple antimicrobial resistance. The different types of gene cassette arrays in the present study highlight the important role of geographical features in MDR isolates dissemination which could be credited to different profiles of drug consumption in different areas. The findings emphasized that the need for continuous surveillance to prevent distribution of multidrug resistance among A. baumannii strains in Iran.
鲍曼不动杆菌的多重耐药菌株在全球范围内引发了治疗难题。本研究旨在确定从伊朗北部巴博勒的支气管肺泡灌洗(BAL)样本中分离出的鲍曼不动杆菌的整合子类型、基因盒及抗菌药物耐药谱。在15个月的时间里,对35株鲍曼不动杆菌分离株进行了研究。使用不同类别的抗菌药物来确定耐药率。采用多重聚合酶链反应(Multiplex-PCR)检测不同类型的整合子及相关基因盒。对庆大霉素(GM)、头孢吡肟(FEP)、阿米卡星(AK)、妥布霉素(TOB)、环丙沙星(CP)、哌拉西林(PIP)、氨苄西林/舒巴坦(SAM)、亚胺培南(IPM)、复方新诺明(SXT)、头孢噻肟(CTX)、头孢他啶(CAZ)、氯唑西林(CL)、替卡西林/克拉维酸(TIM)、美罗培南(MEM)和哌拉西林/他唑巴坦(TZP)的耐药率分别为85.7%、100%、91.4%、68.5%、94.3%、88.5%、97.1%、94.3%、100%、100%、100%、0.0%、91.4%、94.3%和91.4%。int基因的分布分析表明,分别有25.7%、88.6%和28.6%的分离株携带intI、intII和intIII基因。aadB、dfrA1、bla-OXA和aadA1基因的流行率分别为94.3%、77.1%、40%和5.7%。本研究表明,在我们的治疗中心,高水平的鲍曼不动杆菌分离株携带整合子,这可能导致多重耐药性的传播。本研究中不同类型的基因盒阵列突出了地理特征在多重耐药分离株传播中的重要作用,这可能归因于不同地区不同的药物消费情况。研究结果强调,需要持续监测以防止伊朗鲍曼不动杆菌菌株中多重耐药性的传播。